FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Apr. 22, 2015--
MEDNAX, Inc. (NYSE: MD) announced that its Quantum Clinical Navigation
System®, a robust quality and outcomes data tool developed for
its clinicians, has been certified by the Centers for Medicare and
Medicaid Services (CMS) as a Qualified Clinical Data Registry (QCDR).
A QCDR is a new reporting mechanism available for the
Physician Quality Reporting System (PQRS), the CMS program that uses a
combination of incentive payments and payment adjustments to promote
reporting of quality measures. CMS requires a very rigorous
certification process to accept a quality data registry to be a QCDR.
“We are proud to be one of only a few anesthesiology QCDRs in the
country to be designated as such by CMS,” said Katherine Grichnik, M.D.,
Director of Research, Education and Quality. “This certification
provides a strong validation of the organizational commitment we’ve made
to quality and outcomes data at MEDNAX.”
CMS qualified Quantum to report over thirty (30) performance metrics to
be included in the QCDR.
The Quantum Clinical Navigation System was developed at Southeast
Anesthesiology Consultants, which became part of MEDNAX in 2010.
More information can be found about Quantum on the Company’s website at www.mednax.com/why-mednax/health-it.
MEDNAX, Inc. is a national medical group comprised of the nation's
leading providers of neonatal, anesthesia, maternal-fetal and pediatric
physician subspecialty services. Physicians and advanced practitioners
practicing as part of MEDNAX are reshaping the delivery of care within
their specialties and subspecialties, using evidence-based tools,
continuous quality initiatives and clinical research to enhance patient
outcomes and provide high-quality, cost-effective care. Pediatrix
Medical Group, a division of MEDNAX, was founded in 1979 and includes
neonatal physicians who provide services at more than 370 neonatal
intensive care units, and collaborate with affiliated maternal-fetal
medicine, pediatric cardiology, pediatric critical care and other
physician subspecialists to provide a clinical care continuum. Pediatrix
is also the nation's largest provider of newborn hearing screens.
American Anesthesiology, a division of MEDNAX, was established in 2007
and includes more than 2,400 anesthesiologists and advanced
practitioners who provide anesthesia care to patients in connection with
surgical and other procedures as well as pain management. MEDNAX,
through its affiliated professional corporations, employs more than
2,675 physicians in 34 states and Puerto Rico. In addition to its
national physician network, MEDNAX provides services to medical
providers in over 40 states through two complementary businesses,
consisting of a revenue cycle management company and a consulting
services company. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could cause
actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K, filed with the Securities and
Source: MEDNAX, Inc.
Charles Lynch, 954-384-0175, x 5692
President, Strategy and Investor Relations